Laurent Grandidier

AI Medical is shaping the future of neuroradiology by developing cutting-edge intelligent automation software tailored for clinical use. Our mission is to provide an accurate and timely diagnosis for many people around the globe. Current neuroradiological assessment has well-known weak spots – such as human-made errors, fluctuations in quality, and continuously increasing amount of data to be processed. The first product of AI Medical, an intelligent automation software for assessments of magnetic resonance follow-up scans called "Jazz" is intended to address those issues. Jazz has a powerful interactive user interface and built-in AI-based features to provide precise lesion detection and description in a minimal amount of reading time for radiologists. We are here to show how artificial intelligence will transform and empower the practice of neuroradiology and the lives of its patients! For more information on AI-Medical products, please visit our website: https://www.ai-medical.ch/

Aurigin AI a Zurich-based startup on a mission to save the world from AI-generated chaos. Were passionate about building awareness of the evolving quality of AI generated content and protecting everyones trust in content and communication. Think of us as the digital good guys giving you transparency against deepfakes, misinformation, AI manipulated content and all those pesky things that make you question reality.

Hi-D Imaging is a Swiss medtech startup company that is on a mission to redefine the way cardiovascular diseases are understood and treated. Hi-D Imaging develops: - A novel AI-based decision-making support software that is a fusion of different state-of-the-art technologies including deep learning and computer vision, and assists trained healthcare professionals before TAVR operations. - A cutting-edge Digital Twin technology that combines novel in vitro imaging, advanced computer vision, and deep expertise in fluid dynamics and delivers unparalleled insights into cardiovascular treatment planning. This means more precise, patient-specific solutions - helping clinicians and device manufacturers optimize outcomes like never before. Follow Hi-D Imaging for interesting product and industry updates!

atHeart Medical was founded to establish the first transcatheter septal occluder with a metal-free frame, as the new standard of care for atrial septal defects. We have initiated the U.S. FDA approved ASCENT-ASD pivotal trial in the United States and internationally to demonstrate the safety and efficacy of our reSept ASD Occluder for treating patients with clinically significant, isolated ASD. Our name embeds our values: in everything we do, we have clinical excellence and patients at heart.

When everyday activities such as getting up from a chair or walking down the stairs require a great deal of effort, our daily routines can become a big challenge. At MyoSwiss, we are combining robotic and textile technology to help people with muscle weakness regain their mobility and independence. Our Myosuit is an added layer of muscle that supports your movements. MyoSwiss is a Zürich based ETH spin-off that develops medical devices in close collaborations with clinical investigators.

Devogen is a boutique advisory company supporting funds, boards, family offices and executives on strategic subjects

Julier is developing a next generation mechanical thrombectomy solution for the removal of thrombus and revascularization of patients experiencing Acute Ischemic Strokes. The core technology is derived from the work of two serial medtech entrepreneurs, Laurent Grandidier and Niall Behan.

Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. www.xeltis.com

AI Medical is shaping the future of neuroradiology by developing cutting-edge intelligent automation software tailored for clinical use. Our mission is to provide an accurate and timely diagnosis for many people around the globe. Current neuroradiological assessment has well-known weak spots – such as human-made errors, fluctuations in quality, and continuously increasing amount of data to be processed. The first product of AI Medical, an intelligent automation software for assessments of magnetic resonance follow-up scans called "Jazz" is intended to address those issues. Jazz has a powerful interactive user interface and built-in AI-based features to provide precise lesion detection and description in a minimal amount of reading time for radiologists. We are here to show how artificial intelligence will transform and empower the practice of neuroradiology and the lives of its patients! For more information on AI-Medical products, please visit our website: https://www.ai-medical.ch/

Aurigin AI a Zurich-based startup on a mission to save the world from AI-generated chaos. Were passionate about building awareness of the evolving quality of AI generated content and protecting everyones trust in content and communication. Think of us as the digital good guys giving you transparency against deepfakes, misinformation, AI manipulated content and all those pesky things that make you question reality.

Hi-D Imaging is a Swiss medtech startup company that is on a mission to redefine the way cardiovascular diseases are understood and treated. Hi-D Imaging develops: - A novel AI-based decision-making support software that is a fusion of different state-of-the-art technologies including deep learning and computer vision, and assists trained healthcare professionals before TAVR operations. - A cutting-edge Digital Twin technology that combines novel in vitro imaging, advanced computer vision, and deep expertise in fluid dynamics and delivers unparalleled insights into cardiovascular treatment planning. This means more precise, patient-specific solutions - helping clinicians and device manufacturers optimize outcomes like never before. Follow Hi-D Imaging for interesting product and industry updates!

atHeart Medical was founded to establish the first transcatheter septal occluder with a metal-free frame, as the new standard of care for atrial septal defects. We have initiated the U.S. FDA approved ASCENT-ASD pivotal trial in the United States and internationally to demonstrate the safety and efficacy of our reSept ASD Occluder for treating patients with clinically significant, isolated ASD. Our name embeds our values: in everything we do, we have clinical excellence and patients at heart.

When everyday activities such as getting up from a chair or walking down the stairs require a great deal of effort, our daily routines can become a big challenge. At MyoSwiss, we are combining robotic and textile technology to help people with muscle weakness regain their mobility and independence. Our Myosuit is an added layer of muscle that supports your movements. MyoSwiss is a Zürich based ETH spin-off that develops medical devices in close collaborations with clinical investigators.